Norethindrone

Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.

Cross Reference

Introduction

To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Norethindrone?

Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Norethindrone

MeSH term MeSH ID Detail
Pancreatic Neoplasms D010190 77 associated lipids
Body Weight D001835 333 associated lipids
Arteriosclerosis D001161 86 associated lipids
Total 3

PubChem Associated disorders and diseases

What pathways are associated with Norethindrone

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Norethindrone?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Norethindrone?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Norethindrone?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Norethindrone?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Norethindrone?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Norethindrone

Download all related citations
Per page 10 20 50 100 | Total 3869
Authors Title Published Journal PubMed Link
Irvine GA et al. Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia. 1998 Br J Obstet Gynaecol pmid:9647148
Graff-Iversen S et al. Serum lipids in postmenopausal or perimenopausal women using estrogen alone, estrogen with levonorgestrel, or estrogen with norethisterone, compared with nonusers: results from a cross-sectional study in two Norwegian counties 1985-1988. 1998 J Clin Epidemiol pmid:10086825
Mulder TP et al. Effects of hormone replacement therapy on plasma glutathione S-transferase A1-1 concentrations in healthy postmenopausal women. 1998 Clin. Chem. pmid:9510879
Rowlands SC and Dakin L Twelve years of injectable contraceptive use in a general practice. 1998 Br J Fam Plann pmid:9882767
Hägglund H et al. Norethisterone treatment, a major risk-factor for veno-occlusive disease in the liver after allogeneic bone marrow transplantation. 1998 Blood pmid:9845522
Marik JJ Leuprolide acetate depot and hormonal add-back in endometriosis: a 12-month study. 1998 Obstet Gynecol pmid:9572232
Kohnen G et al. Endothelin receptor expression in human decidua. 1998 Mol. Hum. Reprod. pmid:9542978
Leach M et al. Norethisterone therapy for bleeding due to gastrointestinal telangiectases in Glanzmann's thrombasthenia. 1998 Br. J. Haematol. pmid:9504647
Berg G et al. Effect of oral contraceptive progestins on serum copper concentration. 1998 Eur J Clin Nutr pmid:9805216
Hyder SM et al. Progestin regulation of vascular endothelial growth factor in human breast cancer cells. 1998 Cancer Res. pmid:9458078
Barkin JS and Ross BS Medical therapy for chronic gastrointestinal bleeding of obscure origin. 1998 Am. J. Gastroenterol. pmid:9707046
Duckitt K and Shaw RW Is medical management of menorrhagia obsolete? 1998 Br J Obstet Gynaecol pmid:9647144
Tilly-Kiesi M et al. Responses of HDL subclasses, Lp(A-I) and Lp(A-I:A-II) levels and lipolytic enzyme activities to continuous oral estrogen-progestin and transdermal estrogen with cyclic progestin regimens in postmenopausal women. 1997 Atherosclerosis pmid:9105568
Mueck AO et al. Influence of norethisterone acetate and estradiol on the serotonin metabolism of postmenopausal women. 1997 Horm. Metab. Res. pmid:9105905
Diffey B et al. The effect of oral contraceptive agents on the basal metabolic rate of young women. 1997 Br. J. Nutr. pmid:9227183
Rosenfeld WE et al. Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy. 1997 Epilepsia pmid:9070594
Hanson RM and Melzer DJ Estrogen replacement therapy: new options, continuing concerns. 1997 JAMA pmid:9153359
Benagiano G et al. Comparative clinical evaluation of the effect on carbohydrate and lipid metabolism of two norethisterone-containing hormonal contraceptives: Mesigyna and TriNovum. 1997 Contraception pmid:9220226
Haines CJ et al. Sonographic measurement of endometrial thickness as a predictor of vaginal bleeding in women using continuous combined hormone replacement therapy. 1997 Gynecol. Obstet. Invest. pmid:9359646
Martin JG and Buono MJ Oral contraceptives elevate core temperature and heart rate during exercise in the heat. 1997 Clin Physiol pmid:19361151
Nathorst-Böös J and Hammar M Effect on sexual life--a comparison between tibolone and a continuous estradiol-norethisterone acetate regimen. 1997 Maturitas pmid:9032742
Kuhnz W et al. In vivo conversion of norethisterone and norethisterone acetate to ethinyl etradiol in postmenopausal women. 1997 Contraception pmid:9494772
Rossmanith WG et al. A comparative randomized trial on the impact of two low-dose oral contraceptives on ovarian activity, cervical permeability, and endometrial receptivity. 1997 Contraception pmid:9306028
Haapasaari KM et al. Systemic therapy with estrogen or estrogen with progestin has no effect on skin collagen in postmenopausal women. 1997 Maturitas pmid:9255750
Alfie J et al. Hemodynamic effects of transdermal estradiol alone and combined with norethisterone acetate. 1997 Maturitas pmid:9255751
Ulrich LG et al. Quality of life and patient preference for sequential versus continuous combined HRT: the UK Kliofem multicenter study experience. UK Continuous Combined HRT Study Investigators. 1997 Int J Gynaecol Obstet pmid:9386211
Viinikka L et al. Different effects of oral and transdermal hormonal replacement on prostacyclin and thromboxane A2. 1997 Obstet Gynecol pmid:8990448
De Aguilar MA et al. Current status of injectable hormonal contraception, with special reference to the monthly method. 1997 Adv Contracept pmid:9404550
Zhu J et al. [The preparation of poly (DL-lactide) hollow fiber and the release of drug in vitro]. 1997 Sheng Wu Yi Xue Gong Cheng Xue Za Zhi pmid:11326842
Shetty G et al. Use of norethisterone and estradiol in mini doses as a contraceptive in the male. Efficacy studies in the adult male bonnet monkey (Macaca radiata). 1997 Contraception pmid:9408708
Jasonni VM et al. Transdermal progestins in hormone replacement therapy. 1997 Ann. N. Y. Acad. Sci. pmid:9329856
Chryssikopoulos A et al. Cyclic and individualized administration of gonadotropin-releasing hormone agonists plus progestogens: an alternative protocol for contraception. 1997 Gynecol. Endocrinol. pmid:9174853
Singh M et al. Contraceptive efficacy of norethindrone encapsulated in injectable biodegradable poly-dl-lactide-co-glycolide microspheres (NET-90): phase III clinical study. 1997 Adv Contracept pmid:9181181
McCune GS The need for systematic reviews in the treatment of menstrual disorders--another Cochrane collaborative review group is born. 1997 Br J Obstet Gynaecol pmid:9070156
Coulter A and Sheldon T The need for systematic reviews in the treatment of menstrual disorders--another Cochrane collaborative review group is born. 1997 Br J Obstet Gynaecol pmid:9070157
Greyling MD et al. Ligand specificity of uterine oestrogen and progesterone receptors in the subadult African elephant, Loxodonta africana. 1997 J. Reprod. Fertil. pmid:9155728
Schwingl PJ and Shelton J Modeled estimates of myocardial infarction and venous thromboembolic disease in users of second and third generation oral contraceptives. 1997 Contraception pmid:9114999
Ditkoff EC et al. The addition of norethindrone acetate to leuprolide acetate for ovarian suppression has no adverse effect on ovarian stimulation. 1997 J. Assist. Reprod. Genet. pmid:9048239
Singh M et al. Biodegradable norethindrone (NET:cholesterol) contraceptive implants: phase II-A: a clinical study in women. 1997 Contraception pmid:9013058
Comparative study of the effects of two once-a-month injectable steroidal contraceptives (Mesigyna and Cyclofem) on lipid and lipoprotein metabolism. United Nations Development Programme/United Nations Population Fund/World Health Organization/World Bank, Special Programme of Research, Development and Research Training in Human Reproduction. 1997 Contraception pmid:9408700
Ravinder P et al. Pharmacokinetics of orally administered norethisterone enanthate in rabbit, monkey, and women. 1997 Contraception pmid:9262934
Norethin: lower cost can improve OC compliance. 1997 Adv Nurse Pract pmid:9460009
Lübbert H and Nauert C Continuous versus cyclical transdermal estrogen replacement therapy in postmenopausal women: influence on climacteric symptoms, body weight and bleeding pattern. 1997 Maturitas pmid:9522319
Glusa E et al. Mechanisms of relaxation of rat aorta in response to progesterone and synthetic progestins. 1997 Maturitas pmid:9522326
Mc Manus J et al. The effect of hormone replacement therapy on the oxidation of low density lipoprotein in postmenopausal women. 1997 Atherosclerosis pmid:9395275
Weisberg E et al. Effect of different insertion regimens on side effects with a combination contraceptive vaginal ring. 1997 Contraception pmid:9408704
Zeng X and Yao Z Experimental study on relationship between exogenous estrogen and breast cancer risk. 1997 Chin. Med. J. pmid:9594309
Hermans C et al. More on gastric antral vascular ectasia (watermelon stomach) in uremic patients. 1996 Sep-Oct Perit Dial Int pmid:8914187
Wide L et al. Time-related effects of a progestogen on the isoforms of serum gonadotrophins in 17 beta-oestradiol treated post-menopausal women. 1996 Clin. Endocrinol. (Oxf) pmid:8759177
Speroff L et al. The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART study). A randomized controlled trial. 1996 JAMA pmid:8892714
Cerin A et al. Adverse endometrial effects of long-cycle estrogen and progestogen replacement therapy. The Scandinavian LongCycle Study Group. 1996 N. Engl. J. Med. pmid:8592546
Eiken P et al. Effect of 10 years' hormone replacement therapy on bone mineral content in postmenopausal women. 1996 Bone pmid:8922661
DeCherney A Bone-sparing properties of oral contraceptives. 1996 Am. J. Obstet. Gynecol. pmid:8571999
Görög S et al. Analysis of steroids Part 50. Derivatization of ketosteroids for their separation and determination by capillary electrophoresis. 1996 J Pharm Biomed Anal pmid:8818023
Farish E et al. Effects of postmenopausal hormone replacement therapy on lipoproteins including lipoprotein(a) and LDL subfractions. 1996 Atherosclerosis pmid:8879436
Mueck AO et al. Urinary cGMP excretion after hormone replacement therapy in postmenopausal women. 1996 Exp. Clin. Endocrinol. Diabetes pmid:8957275
Schmit A et al. Diagnostic efficacy of push-enteroscopy and long-term follow-up of patients with small bowel angiodysplasias. 1996 Dig. Dis. Sci. pmid:9011441
Istre O et al. Hormone replacement therapy after transcervical resection of the endometrium. 1996 Obstet Gynecol pmid:8885910
Manhem K et al. Estrogen and progestagen modify the hemodynamic response to mental stress in young women. 1996 Acta Obstet Gynecol Scand pmid:8560999
Helle SI et al. Effects of oral and transdermal oestrogen replacement therapy on plasma levels of insulin-like growth factors and IGF binding proteins 1 and 3: a cross-over study. 1996 Clin. Endocrinol. (Oxf) pmid:9039339
Bryner RW et al. Effect of low dose oral contraceptives on exercise performance. 1996 Br J Sports Med pmid:8665116
Pommier F et al. Quantitative determination of norethisterone acetate in human plasma by capillary gas chromatography with mass-selective detection. 1996 J Chromatogr A pmid:8938383
Walle T et al. Stimulatory as well as inhibitory effects of ethinyloestradiol on the metabolic clearances of propranolol in young women. 1996 Br J Clin Pharmacol pmid:8730976
Cédrin-Durnerin I et al. The hormonal flare-up following gonadotrophin-releasing hormone agonist administration is influenced by a progestogen pretreatment. 1996 Hum. Reprod. pmid:8921054
Imthurn B et al. Effect of a programmed short-term stimulation protocol on the replacement of cryopreserved embryos. 1996 J. Assist. Reprod. Genet. pmid:8947818
Nenseter MS et al. Effect of hormone replacement therapy on the susceptibility of low-density lipoprotein to oxidation among postmenopausal hypercholesterolaemic women. 1996 Eur. J. Clin. Invest. pmid:9013080
Couzinet B et al. The antigonadotropic activity of progestins (19-nortestosterone and 19-norprogesterone derivatives) is not mediated through the androgen receptor. 1996 J. Clin. Endocrinol. Metab. pmid:8954018
Evans SF and Davie M Added effect of progestogens on bone mineral density response to oestrogen. 1996 Clin. Endocrinol. (Oxf) pmid:8796150
Marchesoni D et al. Transdermal estroprogestins versus transdermal estrogen plus oral dihydrogesterone replacement in menopause. 1996 J. Endocrinol. Invest. pmid:8796334
Kovacs G Progestogen-only pills and bleeding disturbances. 1996 Hum. Reprod. pmid:8982741
Wonodirekso S et al. Cytokeratin 8, 18 and 19 in endometrial epithelium of Norplant and norethisterone enanthate injectable progestogen contraceptive users. 1996 Hum. Reprod. pmid:8982756
Raymond EG et al. Contraceptive efficacy, pharmacokinetics, and safety of Annuelle biodegradable norethindrone pellet implants. 1996 Fertil. Steril. pmid:8941061
Bozhinova S [The use of the Norcolut preparation in gynecologic; practice]. 1996 Akush Ginekol (Sofiia) pmid:9045566
Dhillon VS and Dhillon IK Genotoxicity evaluation of norethisterone acetate. 1996 Mutat. Res. pmid:8596541
Graff-Iversen S et al. Cardiovascular risk factors in Norwegian women using oral contraceptives: results from a cardiovascular health screening 1985-88. 1996 Contraception pmid:8773420
Valette A et al. Norethindrone stimulates in vivo glycosyltransferases in the rat liver. 1996 Horm. Metab. Res. pmid:8820994
Chitlange SM et al. Ultrasonographic monitoring of ovarian follicles in women using norethisterone for contraception. 1996 Int J Gynaecol Obstet pmid:8737301
Taskinen MR et al. Hormone replacement therapy lowers plasma Lp(a) concentrations. Comparison of cyclic transdermal and continuous estrogen-progestin regimens. 1996 Arterioscler. Thromb. Vasc. Biol. pmid:8857916
Stadberg E et al. 17 beta-estradiol and norethisterone acetate in low doses as continuous combined hormone replacement therapy. 1996 Maturitas pmid:8861084
Dören M and Schneider HP Long-term compliance of continuous combined estrogen and progestogen replacement in postmenopausal women. 1996 Maturitas pmid:8905600
Millions of couples to have choice of injectable contraceptive. 1996 Integration pmid:12347310
Lahdenperä S et al. Effects of postmenopausal estrogen/progestin replacement therapy on LDL particles; comparison of transdermal and oral treatment regimens. 1996 Atherosclerosis pmid:8769679
Klaiber EL et al. Individual differences in changes in mood and platelet monoamine oxidase (MAO) activity during hormonal replacement therapy in menopausal women. 1996 Psychoneuroendocrinology pmid:9044441
Dias Saxena F Family planning and the controversial contraceptives. 1995 Mar-Apr Health Millions pmid:12289896
Sissan MA et al. Effects of low-dose oral contraceptive oestrogen and progestin on lipid peroxidation in rats. 1995 Jul-Aug J. Int. Med. Res. pmid:7589770
Taitel HF and Kafrissen ME Norethindrone--a review of therapeutic applications. 1995 Jul-Aug Int J Fertil Menopausal Stud pmid:8520623
Wright NM et al. Estrogen and diclofenac sodium therapy in a prepubertal female with idiopathic juvenile osteoporosis. 1995 Apr-Jun J. Pediatr. Endocrinol. Metab. pmid:7584708
Kiilholma P et al. Comparison of the gonadotropin-releasing hormone agonist goserelin acetate alone versus goserelin combined with estrogen-progestogen add-back therapy in the treatment of endometriosis. 1995 Fertil. Steril. pmid:7589632
McGee RR Hormone therapy for gastrointestinal bleeding in hereditary hemorrhagic telangiectasia. 1995 South. Med. J. pmid:7481972
van den Brûle FA et al. Absence of antisteroid antibodies in oral contraceptive users presenting with vascular events. 1995 Contraception pmid:8605782
Weisberg E et al. The acceptability of a combined oestrogen/progestogen contraceptive vaginal ring. 1995 Contraception pmid:7750283
Wide L et al. Effect of chronic daily oral administration of 17 beta-oestradiol and norethisterone on the isoforms of serum gonadotrophins in post-menopausal women. 1995 Clin. Endocrinol. (Oxf) pmid:7889633
Wibbels T and Crews D Steroid-induced sex determination at incubation temperatures producing mixed sex ratios in a turtle with TSD. 1995 Gen. Comp. Endocrinol. pmid:8575659
Dören M et al. Superior compliance and efficacy of continuous combined oral estrogen-progestogen replacement therapy in postmenopausal women. 1995 Am. J. Obstet. Gynecol. pmid:7503183
Vanin CM et al. Lumbar vertebral density and mechanical properties in aged ovariectomized rats treated with estrogen and norethindrone or norgestimate. 1995 Am. J. Obstet. Gynecol. pmid:7503190
Schlit AF et al. Large increase in plasmatic 11-dehydro-TxB2 levels due to oral contraceptives. 1995 Contraception pmid:7750285
Görög S et al. Estimation of impurity profiles of drugs and related materials. Part 14: the role of HPLC/diode-array UV spectroscopy in the identification of minor components (impurities, degradation products, metabolites) in various matrices. 1995 J Pharm Biomed Anal pmid:8833970
Pommier F et al. Simultaneous determination of norethisterone and six metabolites in human plasma by capillary gas chromatography with mass-selective detection. 1995 J. Chromatogr. B, Biomed. Appl. pmid:8788144
Jha P et al. Serum norethindrone levels and menstrual pattern after the use of norethindrone implants in rhesus monkeys. 1995 Contraception pmid:7750289
Takada J et al. Pretreatment with low doses of norethindrone potentiates the osteogenic effects of fluoride on human osteosarcoma cells. 1995 J. Bone Miner. Res. pmid:8686507